Artivion | CRY - Operating Profit


Artivion reported $4.79M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Abbott USD 1.85B 399M Mar/2026
Accuray USD 4.71M 6.86M Dec/2024
AngioDynamics USD -2.51M 5.41M Sep/2025
Artivion USD 4.79M 6.85M Dec/2025
AtriCure USD 526K 1.96M Mar/2026
Baxter International USD 66M 280.2M Mar/2026
Becton, Dickinson and Co. USD 627M 36M Mar/2026
Boston Scientific USD 1.05B 190M Mar/2026
Edwards Lifesciences USD 514.7M 144.4M Mar/2026
Inogen USD -7.79M 728K Sep/2024
Integra LifeSciences USD 11.47M 54.54M Mar/2026
J&J USD 6.62B 1.03B Mar/2026
Mesa Laboratories USD 5.78M 2.27M Dec/2024
Orthofix International USD 6.12M 1.91M Dec/2025
Pfizer USD 4.99B 340M Mar/2026
ResMed USD 505.67M 8.07M Mar/2026
Stryker USD 1.1B 867M Mar/2026
Tandem Diabetes Care USD 8.29M 31.16M Dec/2025
Teleflex USD 37.03M 686K Mar/2026
Terumo JPY 31.45B 12.43B Mar/2026
Trinity Biotech USD -509K 6.27M Sep/2025